Analyzing the Future of Orlistat Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the orlistat market size evolved in recent years?
Over the past few years, the market size of orlistat has experienced significant growth. Its expansion from $3.03 billion in 2024 to $3.24 billion the following year, achieving a compound annual growth rate (CAGR) of 6.7%, is notable. The factors contributing to the growth during the historical period include increasing awareness about obesity-related health risks, regulatory acceptance of orlistat as a prescription drug, easy accessibility of lower dosages of orlistat over the counter, recommendations from physicians, and the rising healthcare costs associated with obesity.
What are the predictions for the orlistat market size in the coming years?
In the coming years, the orlistat industry is projected to experience a robust growth, eventually reaching a market size of $4.15 billion in 2029, with a compound annual growth rate (CAGR) of 6.4%. The growth anticipated within this forecast period is primarily due to the increased healthcare expenditure towards obesity treatments, amplified by sedentary living and unhealthy dietary behaviors. Government initiatives encouraging weight loss and healthy lifestyle choices, an aging population, and the transition from prescriptions to over-the-counter options also contribute to this expansion. The key trends expected during this period consist of AI-inspired diet plans, telehealth provisions, automated gadgets to remind patients about medication consumption and monitor compliance, virtual reality exercise regimes, and digital therapeutics.
Get your orlistat market report here!
https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report
What key factors are fueling the growth of the orlistat market?
The orlistat market is predicted to witness significant growth, largely due to the escalating rates of obesity. Obesity, defined as an excessive accumulation of body fat that detrimentally affects health, is typically indicated by a body mass index (BMI) above 30. The rise in obesity can be attributed to factors such as unhealthy eating habits, inactive lifestyles, and inadequate physical exercise. Orlistat, a medication used to manage obesity, works by preventing the digestion and absorption of dietary fats, thereby aiding in weight loss and weight maintenance. For enhanced effectiveness, it usually prescribed along with a low-calorie diet and regular exercise. As per the data from World Health Organization (WHO), a Switzerland-based intergovernmental body, in March 2022, over a billion people worldwide were affected by obesity. This included 650 million adults, 340 million adolescents, and 39 million children. With this number projected to increase, health deterioration due to obesity or overweight conditions is expected to affect approximately 167 million individuals, both adults and children, by 2025. Consequently, this surge in obesity rates is fueling the expansion of the orlistat market.
How is the global orlistat market divided into key segments?
The orlistat market covered in this report is segmented –
1) By Type: 120 Milligram (Mg), 60 Milligram(Mg)
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Weight-Reducing Aid, Other Applications
Subsegments:
1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat, Over-The-Counter (OTC) 120 Mg Orlistat
2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat, Prescription-Based 60 Mg Orlistat
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp
Who are the key firms paving the way for growth in the orlistat market?
Major companies operating in the orlistat market are Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.
What are the key trends shaping the future of the orlistat market?
Major participants in the orlistat market are producing imaginative goods, such as weight control medications, to improve personal cleanliness and convenience through sophisticated technology and design. Weight reduction medication is a kind of treatment created to assist people in losing body weight by curbing their appetite, boosting their metabolism or preventing the absorption of fat. For instance, in November 2023, Eli Lilly and Company, a pharmaceutical corporation based in the United States, attained approval from the US Food and Drug Administration (FDA) for Zepbound (tirzepatide) injection, a novel weight control drug. Zepbound is the inaugural and sole sanctioned treatment that triggers two incretin hormone receptors, GIP and GLP-1, tackling an underlying reason for excess weight. This drug is intended for use as a supplement to a calorie-restricted diet and increased physical exertion to manage weight long term in adults obesed (BMI =30 kg/m²) or overweighted (BMI = 27 kg/m²) with at least one condition linked to weight.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18422
What regions are contributing significantly to the growth of the orlistat market?
North America was the largest region in the orlistat market in 2023. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Oral Care Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report
Oral Contraceptive Pills Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Oral Biologics & Biosimilars Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
